IBTA vs SCSC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IBTA exhibits significant valuation disconnects, trading at a massive premium to its Graham Number ($5.55) and Intrinsic Value ($0.84). While the Piotroski F-Score of 4/9 indicates stable financial health and the balance sheet is clean with very low debt (D/E 0.09), these are overshadowed by deteriorating fundamentals. Revenue growth is negative (-10% YoY) and earnings have collapsed (-87.2% YoY), suggesting the current price is speculative rather than data-driven.
SCSC presents a classic value-trap profile, characterized by a stable Piotroski F-Score of 4/9 and a significant discount to its Graham Number ($55.39) and Intrinsic Value ($57.19). While valuation metrics are exceptionally attractive (P/B < 1.0, PEG 0.58), the company suffers from razor-thin profit margins and stagnant revenue growth. The bullish valuation case is heavily offset by bearish insider activity from the CEO and CFO and a recent decline in quarterly EPS growth. Consequently, the stock is fundamentally undervalued but lacks a clear immediate catalyst for growth.
Compare Another Pair
Related Comparisons
IBTA vs SCSC: Head-to-Head Comparison
This page compares Ibotta, Inc. (IBTA) and ScanSource, Inc. (SCSC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.